India · Delayed Price · Currency is INR GKB Ophthalmics Statistics
Total Valuation
GKB Ophthalmics has a market cap or net worth of INR 337.72 million. The enterprise value is 430.65 million.
| Market Cap | 337.72M |
| Enterprise Value | 430.65M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 5.04M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | -1.08% |
| Owned by Insiders (%) | 66.08% |
| Owned by Institutions (%) | 3.02% |
| Float | 1.23M |
Valuation Ratios
The trailing PE ratio is 10.41.
| PE Ratio | 10.41 |
| Forward PE | n/a |
| PS Ratio | 0.23 |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.28 |
| EV / Sales | 0.29 |
| EV / EBITDA | 4.15 |
| EV / EBIT | 6.03 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | -2.41 |
| Interest Coverage | 4.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.29% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.60M |
| Profits Per Employee | 207,923 |
| Employee Count | 156 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GKB Ophthalmics has paid 1.97 million in taxes.
| Income Tax | 1.97M |
| Effective Tax Rate | 3.45% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 1,345 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GKB Ophthalmics had revenue of INR 1.50 billion and earned 32.44 million in profits. Earnings per share was 6.44.
| Revenue | 1.50B |
| Gross Profit | 421.50M |
| Operating Income | 72.67M |
| Pretax Income | 57.11M |
| Net Income | 32.44M |
| EBITDA | 105.06M |
| EBIT | 72.67M |
| Earnings Per Share (EPS) | 6.44 |
Balance Sheet
The company has 44.17 million in cash and 116.55 million in debt, with a net cash position of -72.38 million.
| Cash & Cash Equivalents | 44.17M |
| Total Debt | 116.55M |
| Net Cash | -72.38M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 548.88M |
| Book Value Per Share | 104.82 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -38.07 million and capital expenditures -10.27 million, giving a free cash flow of -48.34 million.
| Operating Cash Flow | -38.07M |
| Capital Expenditures | -10.27M |
| Depreciation & Amortization | 32.39M |
| Net Borrowing | -28.41M |
| Free Cash Flow | -48.34M |
| FCF Per Share | n/a |
Margins
Gross margin is 28.14%, with operating and profit margins of 4.85% and 2.17%.
| Gross Margin | 28.14% |
| Operating Margin | 4.85% |
| Pretax Margin | 3.81% |
| Profit Margin | 2.17% |
| EBITDA Margin | 7.01% |
| EBIT Margin | 4.85% |
| FCF Margin | n/a |
Dividends & Yields
GKB Ophthalmics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.14% |
| Shareholder Yield | -0.14% |
| Earnings Yield | 9.60% |
| FCF Yield | -14.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |